![]()
-
教授
- 电子邮箱:67c2672a69ffece2e263d43d6980d2186100d4fe81902083c3f7de1727cb593af6097407a927d10869ef2eb6a9a708714a3eb7b6249e40cb388400c134cf3bc2171c66c83d304b9b25e5749e330b536d48eb89f583befd35e128ee864b808eb6b0146cac614998eda59c800457bb4c03c46cb7e8dda09ed9bf080e97c39dee4e
- 学位:博士
访问量:
-
[ 1 ]Jiang W, Wang X, Zeng B, Liu L, Tardivel A, Wei H, Han J, MacDonald HR, Tschopp J, Tian Z, Zhou R. Recognition of gut microbiota by NOD2 is essential for the homeostasis of intestinal intraepithelial lymphocytes.J Exp Med. 2013;21;210(11):2465-76..2021,
-
[ 2 ]Wang X*, Jiang W*, Yan Y, Gong T, Han J, Tian Z, Zhou R. RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat Immunol. 2014;15(12):1126-33.(*co-first author).2021,
-
[ 3 ]Yan Y*, Jiang W*, Liu L, Wang X, Ding C, Tian Z, Zhou R. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015;160(1-2):62-73.(*co-first author).2021,
-
[ 4 ]Tang T, Lang X, Xu C, Wang X, Gong T, Yang Y, Cui J, Bai L, Wang J, Jiang W*, Zhou R*. CLICs- dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation. Nat Commun. 2017;8(1):202.(*co-corresponding author).2021,
-
[ 5 ]Lang X,Tang T,Jin T,Ding C,Zhou R,Jiang W. TRIM65-Catalized ubiquitination is essential for MDA5-mediated antiviral innate Immunity. J Exp Med.2017;214(2):459-473..2021,
-
[ 6 ]Gong T,Wang X,Yang Y,Yan Y,Yu C,Zhou R,Jiang W. Plant Lectins Activate the NLRP3 Inflammasome To Promote Inflammatory Disorders.J Immunol.2017;198(5):2082-2092..2021,
-
[ 1 ]周荣斌 ,邓贤明,江维,何鸿宾,脂肪基取代的噻唑啉酮化合物;其制备方法;药用组合物及应用,201910107444.8,
-
[ 2 ]周荣斌 ,江维,何鸿宾,冬凌草甲素在制备预防或治疗NLRP3炎症小体相关疾病的药物中的应用,201810153535.0,2019/08/23,
-
[ 3 ]周荣斌 ,邓贤明,江维,姜华,陈云,噻唑啉酮杂环化合物、其制备方法、药用组合物及应用,201710494473.5,2019/01/01,
-
[ 4 ]周荣斌 ,江维,黄亿,曲尼斯特的新应用,201710368322.5,2018/12/07,
-
[ 5 ]周荣斌 ,江维,闫宜青,DRD1及其激动剂在制备治疗NLRP3炎症小体相关炎症性疾病药物中的用途,201410541635.2,2015/01/07,2017/12/22.
-
[ 1 ]介导ILC3活化和组织修复的危险识别受体发现及功能研究,进行,
-
[ 2 ]肠道免疫细胞感应肠道微生态菌群中的新型蛋白质机器,进行,
-
[ 3 ]固有免疫与疾病机制,进行,
-
[ 4 ]RIG-I在肠道TRM样细胞形成、维持及肠道免疫防御中的作用和机制研究,进行,
-
[ 5 ]肝脏的“造血免疫器官”功能属性及其调节,进行,
-
[ 6 ]NOD2调节肠道上皮内淋巴细胞发育、分化和存货机制及肠炎相关性研究,完成,